NCT00504530View on ClinicalTrials.gov

r-hLIF for Improving Embryo Implantation in IVF

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2001

Study Completion Date

April 30, 2002

Conditions
Infertility Implantation Failure
Interventions
DRUG

Emfilermin, recombinant human leukemia inhibitory factor (r-hLIF)

All Listed Sponsors
lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT00504530 - r-hLIF for Improving Embryo Implantation in IVF | Biotech Hunter | Biotech Hunter